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Email: mesut_muyan@urmc.rochester.edu)Abstract17b-Estradiol (E2) plays important roles in functions of many tissues. E2 effects are mediated by estrogen receptor (ER)
a and b. ERs regulate transcriptions through estrogen-responsive element (ERE)-dependent and ERE-independent modes
of action. ER binding to ERE constitutes the basis of the ERE-dependent pathway. Direct/indirect ER interactions with
transcription complexes defineERE-independent signaling. ERs share functional features. Ligand-boundERs nevertheless
induce distinct transcription profiles. Live cell imaging indicates a dynamic nature of gene expressions by highlymobile ERs.
However, the relative contribution of ER mobility at the ERE-independent pathway to the overall kinetics of ER mobility
remains undefined. We used fluorescent recovery after a photo-bleaching approach to assess the ligand-mediated
mobilities of ERE binding-defective ERs, EREBD. The decrease in ERa mobility with E2 or the selective ER modulator
4-hydroxyl-tamoxifen (4HT) was largely due to the interaction of the receptor with ERE. Thus, ERa bound to E2 or 4HT
mediates transcriptions from the ERE-independent pathway with remarkably fast kinetics that contributes fractionally to the
overall motility of the receptor. The antagonist Imperial Chemical Industries 182 780 immobilized ERas. The mobilities of
ERb and ERbEBD in the presence of ligands were indistinguishable kinetically. Thus, ERb mobility is independent of the
nature of ligands and the mode of interaction with target sites. Chimeric ERs indicated that the carboxyl-termini are critical
regions for subtype-specific mobility. Therefore, while ERs are highly mobile molecules interacting with target sites with fast
kinetics, an indication of the hit-and-run model of transcription, they differ mechanistically to modulate transcriptions.Journal of Molecular Endocrinology (2012) 49, 249–266Introduction
17b-Estradiol (E2) plays critical roles in many physio-
logical and pathophysiological processes of a wide
range of tissues (Huang et al. 2005a, Zhao et al. 2010).
E2 effects are primarily mediated by transcription
factors, estrogen receptor (ER) a and b, that convey
E2 signaling through estrogen-responsive element
(ERE)-dependent and -independent pathways.
Kinetic biochemical assays indicate that the unli-
ganded ERa interacts, albeit inefficiently, with EREs
cyclically with a time scale of 20 min (Shang et al. 2000,
Metivier et al. 2003, Reid et al. 2003). The binding of E2
to ERa leads to a structural reorganization that
increases the stability of the ERa dimer (Tamrazi et al.
2002) and the affinity of ERa to co-regulatory proteins
(Yi et al. 2002b, Tamrazi et al. 2005). The interaction of
E2–ERa with ERE extends the duration of promoter
engagement to 40–60 min (Shang et al. 2000, Metivier
et al. 2003, Reid et al. 2003). This is due to the sequential
recruitment of preformed co-regulator complexes for
initiation and the subsequent dissociation of complexes
from promoter for termination of transcriptionJournal of Molecular Endocrinology (2012) 49, 249–266
0952–5041/12/049–249 q 2012 Society for Endocrinology Printed in Great Britain(Shang et al. 2000, Metivier et al. 2003, Reid et al.
2003). This episodic ERa–ERE engagement led to the
transcriptional ratchet model that suggests ordered
and directional events for ERE-driven gene expressions.
Fluorescent protein technologies together with
quantitative live cell imaging also indicate a dynamic
transcriptional regulation (Stenoien et al. 2000, 2001a,b,
Sharp et al. 2006, Zwart et al. 2010). These approaches
demonstrated that unliganded ERa exhibits rapid
rates of exchange with chromatin, residence time
measured in milliseconds. Although the binding of E2 to
ERa decreases the mobility of the receptor, the exchange
still occurs in seconds, in a clear contrast with longer
cycling times determined by kinetic biochemical assays.
These fast interactions of ERa with promoters support
the alternative hit-and-run model for transcription.
Along with E2, the activity of ERa is modulated
by the selective ER modulator (SERM) tamoxifen
and antagonist Imperial Chemical Industries 182 780
(ICI) (McDonnell 1999). The binding of SERMs or
antagonists to ERa alters the nuclear mobility and the
ability of ERa to interact with co-regulators and chromatin
(McDonnell 1999, Stenoien et al. 2001b, Yi et al. 2002b).DOI: 10.1530/JME-12-0097
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with transcription factors (Kushner et al. 2000,
Safe 2001). This nuclear signaling route is called
the ERE-independent signaling pathway, which parti-
cipates in the fine-tuning of cellular responses by
regulating the expression of a subset of estrogen-
responsive genes (Li et al. 2008, Nott et al. 2009).
However, the underlying mechanisms or the kinetics
of events at the ERE-independent signaling pathway
remains poorly defined.
Although encoded by a distinct gene, ERb shares
structural features with ERa reflected in similar mode
of action through signaling pathways (Huang et al.
2011). ERb, nevertheless, regulates transcription with
distinct potency and profile in response to ligands at
signaling pathways (Huang et al. 2005a, Zhao et al.
2010). As the nuclear mobility is the sum of ER actions
at target sites on chromatin, we addressed how ligands
affect the nuclear mobility of an ERE binding-defective
ER variant (ERaEBD or ERbEBD) that functions
exclusively at the ERE-independent pathway to obtain
initial insights into mechanisms of ER-mediated gene
expressions. To address this issue, we used green
fluorescence protein (GFP) fusion-ERs and fluorescent
recovery after a photo-bleaching (FRAP) approach.
We found that the ligand-mediated nuclear mobility of
ERa largely reflects the ability of the receptor to interact
with ERE, whereas the mobility of ERb is independent
of the nature of ligands and the ability of ERb to bind
to ERE. Thus, ERs are highly mobile molecules inter-
acting with target sites with fast kinetics, an indication
of the hit-and-run model of transcription, and they
differ mechanistically to modulate transcriptions.Materials and methods
Plasmids
The expression vectors bearing human ERa and ERb
cDNAs encoding 595 and 530 amino acid long
receptors respectively and the cDNA encoding the
designer transcription factor PPVV were described
previously (Yi et al. 2002a, Huang et al. 2004). The
AF2 mutant of ERa contains a three amino acid
replacement (D538A, E542A, and D545A) that blocks
the ligand-dependent activation function (AF2) of ERa
(Tzukerman et al. 1994, Sathya et al. 2002, Yi et al.
2002a). We initially used an AF2 mutant of ERb that
contains analogous mutations to that of ERa as we
described previously (Yi et al. 2002a). However, the
presence of the GFP at the amino-terminus of this
mutant renders the receptor toxic to cells as they died
before experimentation. To circumvent this problem,
we used a point mutation that changes only the Glu
residue at position 493 to a Lys in ERb that prevents AF2Journal of Molecular Endocrinology (2012) 49, 249–266(An et al. 1999). The EREBD were described previously
(Li et al. 2008, Nott et al. 2009). The ERaEBD contains
Ala, Ala, and Glu residues at positions 203, 204, and 211
respectively that replace Glu, Gly, and Arg at the
corresponding positions in the DNA recognition helix
of the first zinc finger critical for ERa–ERE interactions
(Nott et al. 2009). The replacement of Glu and Gly
at positions 167 and 168 respectively in the DBD of
ERb with Ala residues generates the ERbEBD (Li et al.
2008). The chimeric ERaNbC or ERbNaC, generated
by genetically exchanging sequences that encode the
entire amino-terminal region of ERb or ERa with that
of ERa or ERb, were also described previously (Yi et al.
2002a). cDNAs also contain sequences that encode a
Flag epitope at the amino-terminus.
For the engineering of GFP fusion proteins, a
restriction enzyme site was engineered at the 5 0 of
the start codon of ER cDNAs using an overlapping
PCR. The engineered cDNAs were inserted into the
3 0 end of the reading frame of the GFP-cDNA in the
pAcGFP-C1 expression vector (Clontech) with appro-
priate restriction enzyme sites. For comparative analysis
of GFP-ERs in some biochemical assays, we also
generated a GFP cDNA with sequences that encode
a Flag epitope at the amino-terminus of the protein.
All constructs were sequenced to ensure the fidelity
of encoding sequences.
We assessed the effect of ligands on ERE-driven gene
expression using reporter vectors that emulate the
ERE-dependent signaling pathway. For the simple
TATA box promoter, we used the reporter pGL3
(Promega Corp.) plasmids bearing a TATA box
promoter with single (ERE) or two EREs (2XERE)
(Sathya et al. 2002, Yi et al. 2002a). We also used the
pGL3 reporter vector bearing the promoter of the
trefoil factor 1, TFF1, or pS2 gene (TFF1-Luc) (Yi et al.
2002a). To simulate ERE-independent signaling,
we used an MMP1-Luc reporter plasmid that bears a
fragment of the proximal promoter of the matrix
metallopeptidase 1, MMP1, gene with single AP1
response element (Webb et al. 1995, Huang et al.
2004, Li et al. 2004) or an RARA-Luc reporter vector
derived from the proximal promoter of the retinoic
acid receptor a, RARA, gene that contains two GC-boxes
(Sun et al. 1998, Huang et al. 2004, Li et al. 2004).
In all reporter vectors, promoters drive the expression
of the firefly luciferase cDNA as the reporter enzyme.
A reporter vector driving the expression of the Renilla
luciferase cDNA (Promega) was used to assess trans-
fection efficiency (Yi et al. 2002a, Huang et al. 2004).
The ratio of the firefly/Renilla luciferase activities of
the cell lysate was determined using a dual luciferase
assay kit (Promega Corp.) to obtain the relative
luciferase activity.
The Flag M2 antibody, ERa-specific H-222, and
ERb-specific antibody D7N were purchased fromwww.endocrinology-journals.org
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Zymed Laboratories, Inc. (San Francisco, CA, USA)
respectively.
E2 and 4-hydroxyl-tamoxifen (4HT) were purchased
from Sigma–Aldrich. ICI was obtained from Tocris
Biosciences (Ellisville, MO, USA). Restriction and DNA-
modifying enzymes were purchased from New England
Bio-Labs (Beverly, MA, USA) and Invitrogen Corp.Transient transfections
Transient transfections for simulated ERE-dependent
and ERE-independent pathways were accomplished as
described previously (Yi et al. 2002a, Huang et al. 2004,
Li et al. 2004). Transfected cells were treated without
or with 10K9 M E2 in the absence or presence of
10K7 M 4HT and/or 10K7 M ICI for 24 h to examine
the effects of ligands on ER-mediated transcriptional
responses from the ERE-dependent and ERE-
independent signaling pathways.In situ E2 binding assay
To assess the synthesis and function of GFP fusion ERs
in transfected cells, we used an in situ E2 binding assay
described previously (Huang et al. 2005b, Li et al.
2008). Briefly, transiently transfected cells in 48-well
tissue culture plates were incubated with 10K7 M of
(2,4,6,7,16,17-3H) E2 (118 Ci/mmol, NEN Life
Sciences, Boston, MA, USA) in the absence or presence
of 10K6 M 4HT or ICI for 1 h. Cells were then washed
extensively with PBS, collected, and radioactivity
remaining in cells was measured in a scintillation
counter. By the use of in situ ligand binding assay,
we estimate that transiently transfected HeLa and
MDA-MB-231 cells synthesize about 5.5- and 4-fold
respectively more ERa compared with MCF-7 cells,
a breast adenocarcinoma cell line that endogenously
synthesizes ERa (Eckert et al. 1984).In situ competition for ERE binding assays
In situ competition for ERE binding assay (Huang
et al. 2005b) was used to assess the ability of GFP-ERs
to interact with ERE in situ. This assay is based on
the interference of a constitutively active potent
activator (PPVV)-mediated transcription from a single
ERE-driven promoter construct by unliganded or
ligand-bound ERs. The extent of interference is then
taken as an indication of ER–ERE interactions (Huang
et al. 2005b). In brief, cultured cells in 48-well tissue
wells were transfected with 125 ng simple TATA box
promoter with one ERE and 300 ng expression vector
carrying the PPVV cDNA together with 0, 75, 150, or
300 ng expression vector containing the cDNA for anwww.endocrinology-journals.orgER. Appropriate amounts of the parent expression
vector were added into a given reaction to equalize the
total amount of plasmid DNA. A vector bearing the
Renilla luciferase cDNA was used as an internal control
in the amount of 0.5 ng to normalize the transfection
efficiency. Four hours after transfection, cells were
maintained in fresh medium supplemented with
10% CD-FBS in the absence or presence of 10K9 M
E2, 10
K7 M 4HT, or ICI for 24 h.Western blot and electrophoretic mobility shift assay
Transiently transfected cells with expression vectors in
six-well tissue culture plates were maintained for 24 h.
Cell extracts (10 mg) were subjected to western blot
(WB) and electrophoretic mobility shift assay (EMSA)
as detailed previously (Li et al. 2008, Nott et al. 2009).
For WB, proteins were probed with the HRP-conjugated
monoclonal Flag antibody (M2-HRP, Sigma–Aldrich).
We also used HC-20 and D7N antibodies (Santa Cruz
Biotechnology, Inc.) specific to ERa and ERb respect-
ively to detect receptor proteins, which were visualized
with a second antibody conjugated with HRP. The ECL-
Plus Western Blotting kit (GE Life Sciences, Piscataway,
NJ, USA) was used for the detection of receptor
proteins. For EMSA, we used the Flag or a receptor-
specific antibody to assess the specificity of ER–ERE
interactions. Images from WB and EMSA were analyzed
by PhosphorImager (Storm 860, GE Life Sciences) and
were quantified with ImageQuant (GE Life Sciences).
We also examined the effects of ER ligands on the
detergent extractability and intracellular level of
receptor proteins with WB. Cells maintained in six-
well tissue culture plates in 10% CD-FBS containing
media for 24 h were then transiently transfected for
24 h. Cells were subsequently incubated with fresh
medium supplemented with or without 10K9 M E2,
10K7 M 4HT, or ICI for 1 h. At the termination of an
experiment, cells were collected, pelleted, and
subjected to protein extraction using 50 ml of a high
salt extraction buffer, HSB (400 mM KCl, 20% glycerol,
2 mM dithiothreitol (DTT), 1 mM phenylmethyl-
sulphonyl fluoride (PMSF), and 1/14 (v/v) protease
inhibitor cocktail, Roche Diagnostics), or RIPA buffer
(0.5% sodium deoxycholate, 1% Igepal CA-630,
0.1% SDS, 2 mM DTT, 1 mM PMSF, and 1/14 (v/v)
protease inhibitor cocktail). After the HSB or RIPA
extraction, the remaining pellet was also subjected to
50 ml 1! Laemmli buffer (LB) (60 mM Tris–Cl,
pH 6.8, 2% SDS, 10% glycerol, 5% b-mercaptoethanol,
and 0.01% bromophenol blue), to extract insoluble
protein aggregates. In addition, we used 100 ml LB
to obtain total cell lysate (TCL) by extracting
both soluble and insoluble proteins. Ten micro-
grams of total protein estimated with NanodropJournal of Molecular Endocrinology (2012) 49, 249–266
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to 10–18% SDS-PAGE.Chromatin immunoprecipitation assay
Chromatin immunoprecipitation assay (ChIP) assay was
described previously (Huang et al. 2005b). In brief, cells
grown in six-well tissue culture plates were co-trans-
fected with expression vector and the reporter vector
bearing the TATA box promoter with single ERE.
Twenty-four hours after transfection, cells were incu-
bated in fresh medium with or without 10K7 M E2, 4HT,
or ICI for 1 h. Cells were then subjected to ChIP using
the Flag-M2 antibody-conjugated agarose beads
(Sigma–Aldrich). The generation of a 366 bp PCR
fragment by ChIP indicates the specificity of PCRs. Due
to the difficulty of assessing the interaction of ER with
EREs of endogenous genes by ChIP in transiently
transfected cells, we used recombinant adenovirus-
infected MDA-MB-231 cells with which we previously
carried out experiments to assess the interactions of
E2–ERs with (Huang et al. 2005b), and transcriptional
responses from Li et al. (2008), Nott et al. (2009) and
Huang et al. (2011), the ERE of TFF1. MDA-MB-231
cells, 100 000 cells/well in six-well tissue culture plates,
were infected with recombinant adenoviruses in
media with 10% CD-FBS for 48 h. We used recombinant
adenovirus bearing ERa, ERaEBD, ERb, or ERbEBD
cDNA with sequences encoding a Flag epitope at the
amino-terminus at 100, 150, 600, or 900 multiplicity of
infection (MOI) respectively together with the parent
recombinant adenovirus bearing no cDNA at varying
MOI to equalize the total amount of adenovirus,
900 MOI, used for infections. At these MOIs, the
synthesis of ERs was comparable (Li et al. 2008, Nott
et al. 2009, Huang et al. 2011). Forty-eight hours after
infections, cells were incubated in fresh medium
supplemented without or with 10K9 M E2, 10
K7 M
4HT, or ICI for 1 h. We also used 10K8 M ERa-selective
propyl pyrazole triol agonist or 10K8 M ERb-selective
diarylpropionitrile agonist for 1 h. At these concen-
trations, ligands maximally affected transcriptional
responses from reporter constructs induced by ERs or
E2–ERs (data not shown). Cells were collected and
subjected to ChIP using M2-Flag antibody-conjugated
agarose beads (Sigma–Aldrich) as described (Huang
et al. 2005b). The production of a 315 bp PCR product
indicates specific ER–ERE interactions (Supplementary
Figure 3A, see section on supplementary data given at
the end of this article).Live cell microscopy and FRAP
HeLa or MDA-MB-231 cells were grown in 35 mm glass
bottom coverslip dishes (MatTek Corp., Ashland, MA,Journal of Molecular Endocrinology (2012) 49, 249–266USA) in medium containing 10% CD-FBS without
phenol-red for 24 h. Cells were then transiently
transfected with 1.5 mg of an expression vector bearing
the GFP-fusion receptor cDNA. Twenty-four hours after
transfections, cells were treated with or without various
concentrations (10K10 to 10K7 M) of E2 for 1 h before
FRAP analysis. We observed in preliminary studies that
10K9 M E2 maximally affected the intracellular mobility
of both ERa and ERb. Based on these findings, we used
10K9 M E2 in subsequent FRAP assays. We also treated
cells with 10K7 M 4HT or ICI, a concentration that
maximally affected the nuclear mobility of ERs in
preliminary experiments. FRAP was performed using
an Olympus FV1000 laser scanning confocal
microscope containing a full-stage incubator equili-
brated to 37 8C housed at the URMC Confocal and
Conventional Microscopy Core. Cells were imaged live
using a 60! 1.4 NA oil immersion objective.
Cells were initially examined with differential
interference contrast (DIC) to assess the cellular health.
To prevent experimental artifacts due to over-expression
of GFP-fusion ERs (Stenoien et al. 2001a,b), cells with low
fluorescence intensities (600–1500 arbitrary fluorescence
unit) were selected for FRAP analysis. Photo-bleaching
was accomplished using a tunnel region of interest (ROI)
of the FRAP module. A tunnel ROI as a 9!9 pixel
area (4.468 mm2) was used for all photo-bleaching
experiments. It should be noted that the FRAP results
were independent of the shape of ROI, as we obtained
similar results from stripe bleaching in preliminary
experiments (data not shown). A single z plane was
bleached with the SIM scanner capabilities using the
405 nM laser set to 30% power for 0.2 s and simul-
taneously imaged in freerun (w0.25 ms intervals) mode.
FRAP analysis was carried out with FV1000 Olympus
post-processing software. Briefly, frames of the time-
lapse data were moved to the point of photo-bleaching
and graphs were obtained for the bleached ROI.
Another ROI at a size and fluorescence intensity that
corresponded to those of the experimental ROI before
photo-bleaching within the same cell was used as the
control to assess the background and alterations in total
cellular fluorescence due to photo-bleaching (Supple-
mentary Figure 1, see section on supplementary data
given at the end of this article). All data were exported
to Excel for further analysis. The fluorescence intensity
of the control ROI throughout the post-bleach period
was used to normalize the recovery of bleached ROI by
dividing the fluorescence value of the bleached ROI
with that of the control ROI at each time point of
imaging. Fluorescence is expressed as relative fluor-
escence units where zero (0) is the fluorescence after
photo-bleaching (time 0) and one (1) is the fluor-
escence of the bleached area reached to pre-bleach
levels. Images were exported as Tagged Image File
Format (tif) and movie (mov) files. Adobe Photoshopwww.endocrinology-journals.org
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All experiments were carried out using five to seven
individual cells per experiment. Results were repeated
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Figure 1 The synthesis of functional GFP-ERs in HeLa cells.
(A) The synthesis of ER species. HeLa cells were transiently
transfected with an expression vector bearing none (V) or an ER
cDNA with or without sequences encoding GFP (G) genetically
conjugated to the 5 0 of ER coding sequences. Constructs also
contain sequences that encode for a Flag epitope present at the
amino-terminus of the resulting protein. Cell extracts (10 mg) were
subjected to WB using a HRP-conjugated monoclonal Flag
antibody. Molecular mass in kDa is indicated. (B) In situ E2 binding
assay. Twenty-four hours after transient transfections with an
expression vector bearing none (V) or an ER cDNA with (G) or
without GFP, HeLa cells were incubated in medium containing
10K7 M of 3H-E2 in the absence or presence of 10
K6 M 4HT
(C4HT) for 1 h. The medium containing the radioactive 3H-E2
was removed and cells were extensively washed with PBS before
dislodging. Radioactivity retained in cells was then quantified by
scintillation counting. The graph represents the meanGS.E.M. of
three independent experiments performed in duplicate. (C) The
interaction of ERs with ERE in vitro. Cell extracts (10 mg) of
transfected cells were also subjected to electrophoretic mobility
shift assay (EMSA) without (K) or with (C) a receptor-specific
antibody (Ab). ERE specifies unbound and ER-ERE denotes
ER-bound radiolabeled ERE. Asterisk denotes the free ERE lane.
A representative result from a minimum of two independent
experiments of WB or EMSA is shown.Results
The synthesis and function of GFP-ERs in HeLa cells
The interaction of ERa with permutations of a core
palindromic DNA sequence 5 0-GGTCAnnnTGACC-3 0,
or ERE as well as ERE half-sites (Kato et al. 1995, Ansari
et al. 2012), constitutes the ERE-dependent signaling
pathway (Huang et al. 2005a, Zhao et al. 2010). The
recognition of an ERE by the ERa dimer is mediated by
two zinc-binding motifs in each DBD monomer that
fold to form a single functional unit (Schwabe et al.
1993). Distinct residues particularly Glu203 and Gly204
in the DNA recognition helix of the first zinc finger of
DBD of the human ERa are critical for DNA sequence
discrimination (Schwabe et al. 1993) and also for
binding to EREs (DeNardo et al. 2007). We showed
that changing Arg211, a conserved amino acid among
nuclear hormone receptors critical for receptor–DNA
interactions, to Glu211 together with Ala203 and Ala204,
which replace Glu203 and Gly204 respectively, generates
ERaEBD that functions only at the ERE-independent
signaling pathway (Nott et al. 2009). Similarly, changing
Glu167 and Gly168 in the first zinc finger motif of the
DBD of the human ERb to Ala also generated ERbEBD
that regulates gene transcriptions exclusively through
the ERE-independent signaling pathway (Bjornstrom &
Sjoberg 2002, Li et al. 2008).
To examine the effects of ligands on the kinetics of
nuclear movement of EREBD, we initially assessed the
synthesis and biochemical features of GFP fusion
receptors in comparison with the wild-type counter-
parts in transiently transfected HeLa cells derived from
an ER-negative cervical carcinoma. Cellular extracts
were subjected to WB using an antibody specific to the
Flag epitope present at the amino-terminus of each
receptor (Fig. 1A). Results revealed that HeLa cells
synthesize GFP-ERs with expected molecular mass. The
treatment of cells with a saturating concentration of
3H-E2 (10
K7 M) showed that the radiolabeled E2 is
retained in cells synthesizing a GFP-ER as observed in
cells synthesizing an ER (Fig. 1B). The treatment of
cells with 10K6 M 4HT or ICI (data not shown)
effectively prevented the retention of 3H-E2. Thus, the
presence of GFP at the amino-termini of ERs has little
effect on the synthesis and the ligand binding abilities
of the fusion receptors.
To assess the interaction of GFP-ERs with ERE, we
employed EMSA with cellular extracts from transiently
transfected HeLa cells (Fig. 1C). Displaying similarwww.endocrinology-journals.org Journal of Molecular Endocrinology (2012) 49, 249–266
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GFP-ERa and GFP-ERb retarded the migration of the
radiolabeled ERE, whereas GFP-ERaEBD, GFP-ERbEBD,
or the EREBD showed no binding.
To further ensure that GFP-ERs in response to
ligands mimic the effects of the parent ERs on the
transcription and GFP-ERsEBD are functional only at
ERE-independent signaling pathways, we used reporter
vectors with promoters emulating ERE-dependent and
ERE-independent signaling routes (Supplementary
Figures 2 and 3, see section on supplementary data
given at the end of this article). For the simulated
ERE-dependent signaling pathway, we used reporter
plasmid bearing two EREs in tandem located upstream
of the simple TATA box promoter (2XERE-Luc) or the
proximal promoter region derived from the TFF1 gene
(TFF1-Luc) bearing an ERE. ERa increased the activity
of the reporter enzyme in response to a physiological
concentration (10K9 M) of E2 from both promoters in
transfected cells (Supplementary Figure 2A). Although
the extent of activations was lower than those induced
by ERa, GFP-ERa also increased the enzyme levels in
response to E2. The treatment of cells with 10
K7 M 4HT
or 10K7 M ICI alone had little effect on transcriptional
responses mediated by ERs or GFP-ERs. However, 4HT
or ICI effectively countered the effect of E2 on the
reporter enzyme when cells were co-treated, whereas
ERaEBD or GFP-ERaEBD did not affect the enzyme
activity whether or not cells were exposed to ligands
alone or in combination. Similarly, ERb or GFP-ERb, but
not the ERE binding-defective counterparts, augmen-
ted the activity of the reporter enzyme only in the
presence of E2, which was blocked by the co-treatment of
cells with 4HT or ICI (Supplementary Figure 3A). Thus,
GFP-ERs, but not the EREBD with or without GFP, in
response to ligands mimic the effects of the parent ERs
on the transcription of the reporter enzyme mediated
through the ERE-dependent signaling pathway.
We previously showed that MMP1 is a target gene for
E2–ER signaling, as ERs in response to 10
K9 M repress
the expression of MMP1 through the ERE-independent
signaling pathway (Li et al. 2008, Nott et al. 2009).
Simulated systems suggest that the functional
interaction of ERs with AP1 bound to an AP1 element
provides the basis for the regulation of MMP1 gene
promoter in an ER subtype, nature and concentration
of ligand, promoter and cell type-dependent manner
(Webb et al. 1995, Kushner et al. 2000). Similarly, the
interaction of ER with SP1 bound to GC boxes is critical
for the ligand-mediated regulation of the RARA gene
promoter in reporter assays (Sun et al. 1998, Safe 2001).
To ensure that GFP-ERs also mimic the effects of the
parent ERs on transcription, an expression vector
bearing none or an ER cDNA was transfected into
HeLa cells together with MMP1-Luc or the RARA-Luc
reporter vector (Supplementary Figure 2B and 3B).Journal of Molecular Endocrinology (2012) 49, 249–266We did not observe a significant effect of 10K9 M E2
mediated by ERs with or without GFP on the activity of
the reporter enzyme from promoters, which could
be due to the promoter composition in reporter
constructs. However, 10K7 M 4HT mediated transcrip-
tional responses to ERs similarly. ICI at 10K7 M also
affected the luciferase activity mediated by ERa
proteins, but not by ERb with or without GFP.
Importantly, EREBD mimicked the effects of the parent
ERs on transcriptions in response to ligands from
reporter vectors emulating ERE-independent signaling
pathways. Thus, the presence of GFP at the amino-
termini of ERs does not affect the transregulatory
functions of the receptors at simulated ERE-independent
signaling pathways as well.Ligand-mediated nuclear mobility of GFP-ERs
To examine the effects of ligands on nuclear mobility of
ERs with or without ERE binding function, transfected
HeLa cells were treated with a vehicle (EtOH, 0.01%)
for 1 h and then subjected to FRAP analysis (Fig. 2).
GFP-ERa showed a diffuse distribution throughout
the nucleus but it is excluded from nucleoli. After a
0.2-s photo-bleaching, the bleached area equilibrated
to pre-bleach levels within 1 s with a half-maximum
recovery rate (1⁄2mRR) of !0.2 s. On the other hand,
the treatment of cells with 10K9 M E2 or 10
K7 M 4HT for
1 h reduced the mobility of the receptor. Fluorescence
after photo-bleaching was fully recovered within 40 s of
post-bleaching with a 1⁄2mRR of about 5 s. By contrast,
the treatment of cells with 10K7 M ICI immobilized
GFP-ERa as no fluorescence recovery was observed
(up to 15 min, data not shown) in post-bleaching.
Consistent with previous studies (Stenoien et al. 2000,
2001a,b, Sharp et al. 2006, Zwart et al. 2010), our results
also demonstrate that GFP-ERa in the unliganded state
is a highly mobile molecule and shows different kinetics
of mobility in response to ligands.
Similar to the unliganded GFP-ERa, GFP-ERaEBD in
the absence of a ligand showed a rapid mobility with
1⁄2mRR of !0.2 s (Fig. 3). Although the treatment of
cells with 10K9 M E2 or 10
K7 M 4HT for 1 h slowed the
nuclear mobility of GFP-ERaEBD with a 1⁄2mRR of about
1 s, the full fluorescence recovery occurred within
10 s of post-bleaching, much faster kinetics than that
observed with E2- or 4HT-liganded ERa. These results
indicate that the E2- or 4HT-mediated decrease in
the nuclear mobility of ERa is primarily due to the
interaction of the receptor with ERE. ICI, on the other
hand, prevented the mobility of GFP-ERaEBD in the
majority of cells (more than 80%). However, in
the remaining cell population, GFP-ERaEBD in
response to ICI showed mobility with varying 1⁄2mRRs
(Supplementary Figure 4, see section on supplementary
data given at the end of this article). These resultswww.endocrinology-journals.org
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Figure 2 The assessment of nuclear mobility of GFP-ERa by FRAP. HeLa cells
transiently transfected with GFP-ERa for 24 h were treated without (NL) or with 10K9 M E2,
10K7 M 4HT, or ICI for 1 h. Cells were then subjected to FRAP analysis. Images were
obtained before bleaching (pre-bleach, PB), at bleaching for 0.2 seconds (bleach, B), and
at the indicated times in seconds after bleaching. The overlay image (Overlay) was
generated with the superimposition of images from DIC and GFP. The time-dependent
equilibration of the bleached area (within the white circle) was used to estimate the
recovery rate of ER in response to ligands. The recovery rate was based on a control ROI
with the size and fluorescence intensity that corresponded to those of the ROI (bleached
area) before photo-bleaching within the same cell to normalize the background and
alterations in total cellular fluorescence after bleaching (Supplementary Figure 1).
The control ROI values obtained throughout the post-bleach period were then used for
data normalization. Fluorescence intensity is expressed as the relative fluorescence (RF)
where zero (0) is the RF at the photo-bleaching (time 0) and one (1) is the fluorescence of
the bleached area equilibrated to pre-bleach levels. Graph represents the normalized
mean fluorescence recovery of GFP-ERa with or without a ligand in three independent
experiments with a minimum of five individual cells per experiment. S.E.M., which was
!15% of the mean, is not shown for simplicity.
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Figure 3 The kinetics of nuclear mobility of GFP-ERaEBD. Transiently transfected HeLa
cells were treated without or with ligands for 1 h and subjected to FRAP analysis as
described in the legend of Fig. 2. Graph represents the normalized mean fluorescence
recovery of GFP-ERaEBD in three independent experiments with a minimum of five
individual cells per experiment. S.E.M., which was !15% of the mean, is not shown
for simplicity.
M MUYAN and others . Mobility and ERE interactions of ERs256suggest that the DBD of ERa contributes to but it is not
sufficient for the ICI-mediated immobilization of ERa.
GFP-ERb (Fig. 4A) and GFP-ERbEBD (Fig. 4B)
displayed similar patterns of intra-nuclear distribution
and kinetics of mobility. In cells synthesizing ERb
or ERbEBD in response to the vehicle control, the
fluorescence recovery of the region after a 0.2-s photo-
bleaching occurred with a 1⁄2mRR of about 1 s that
reached pre-bleach fluorescence intensities within 40 s
of post-bleaching. These results, as shown for ERb
(Damdimopoulos et al. 2008), indicate that the
mobilities of the unliganded ERb variants are kineti-
cally slower than the corresponding ERa species.
This was also the case for the E2- or 4HT-liganded
ERb proteins. Treatment of cells with 10K9 M E2 or
10K7 M 4HT decreased the mobility of the receptors
that was reflected in 1⁄2mRRs of about 15 s with full
recoveries occurring within 90 s after bleaching.
Remarkably, both GFP-ERb and GFP-ERbEBD in theJournal of Molecular Endocrinology (2012) 49, 249–266presence of 10K7 M ICI displayed mobilities that were
kinetically indistinguishable from those of the E2- or
4HT-bound receptors, in contrast to ERa species that
were stationary in the presence of ICI. Thus, the ability
of ERb to bind to ERE is uncoupled from the nuclear
mobility of the receptor independent of the nature
of ligand.
In addition to alterations in the stability, turnover,
and intracellular location of ERa (Dauvois et al.
1992), ICI rapidly sequesters the receptor to a sub-
compartment that also involves the nuclear matrix
resistant to detergent and salt extractions (Stenoien
et al. 2000, 2001a,b, Long & Nephew 2006, Lupien et al.
2007). This sequestration appears to be responsible for
the immobilization (Stenoien et al. 2000, 2001a,b,
Reid et al. 2003) and the absence of interaction with
ERE (Reid et al. 2003) of the receptor. By contrast, ICI
does not affect the turnover of ERb (Peekhaus et al.
2004, Long et al. 2010).www.endocrinology-journals.org
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Figure 4 The assessment of the ligand-mediated mobility of GFP-ERb (A) and GFP-ERbEBD (B) by FRAP. Transient
transfection and processing of HeLa cells for FRAPwere carried out as described in the legend of Fig. 2. The normalizedmean
fluorescence recovery of GFP-ERb species without (NL) or with a ligand from three independent experiments with a minimum
of five individual cells per experiment was graphed without S.E.M., which was !15% of the mean.
Mobility and ERE interactions of ERs . M MUYAN and others 257Indeed, ERa (Fig. 5A) and ERb (Fig. 5D) with or
without GFP showed different intracellular levels in the
presence of ICI. Transiently transfected HeLa cells
synthesizing ERa or GFP-ERa for 24 h were treated with
or without 10K9 M E2, 10
K7 M 4HT, or ICI for 1 h. Cells
were then subjected to protein extractions using a
buffer containing high salt (HSB) or detergent (RIPA,
data not shown). Extracts (10 mg) were then subjected
to WB. While E2 or 4HT had minimal effect on ERa
levels at 1 h posttreatment, ICI substantially reduced
the receptor level in HSB extracts. This was inversely
correlated with the detection of a higher receptor
amount in ICI, but not E2 or 4HT, treated cell extracts
obtained with 1! LB to solubilize the insoluble
aggregates following HSB extractions. By contrast, WB
of TCLs generated with LB to extract both soluble and
insoluble protein aggregates revealed that ligands had
minimal effects on total receptor levels. This suggests
that ICI-mediated rapid immobilization of ERa variants
is primarily independent of the receptor degradation.
A rapid sequestration of ERa with or without GFP
by ICI to a nuclear sub-compartment resistant to
HSB extraction also predicts that ICI prevents thewww.endocrinology-journals.orginteraction of GFP-ERa with ERE, as shown previously
for ERa (Reid et al. 2003). To address this point, we
employed ChIP assay (Fig. 5B). The expression vector
bearing none or an ER cDNA was co-transfected with
the reporter TATA box promoter vector bearing one
ERE into HeLa cells. Cells were treated with or without
10K9 E2, 10
K7 4HT, or ICI for 1 h and processed for
ChIP using a Flag antibody. Results revealed that the
binding of apoERa to ERE is augmented when cells
were treated with E2 or 4HT. ICI effectively prevented
ERa–ERE interaction, as there was no PCR product. In
clear contrast, E2 or ICI had minimal effects on the
binding of ERb to ERE (Fig. 5E). On the other hand,
4HTenhanced the binding of ERb to ERE. As expected,
ERaEBD or ERbEBD did not interact with ERE whether
or not cells were treated with a ligand.
To correlate the intracellular mobility of GFP-ERs to
ERE binding using ChIP with various antibodies
directed to different structural domains of fusion
receptor with or without Flag epitope proved to be
difficult. To circumvent this problem, we used an in situ
ERE binding competition assay (Huang et al. 2005b).
This assay is based on the ability of ER to compete forJournal of Molecular Endocrinology (2012) 49, 249–266























































































































































































Figure 5 Effects of ligands on protein levels and ERE interactions of ER and EREBD with or without GFP. (A) Transiently transfected
HeLa cells for 24 h were incubated with fresh media supplemented with or without 10K9 M E2, 10
K7 M 4HT, or ICI for 1 h. Cells were
then collected, washed, re-suspended in 1 ml PBS, and divided into two equal portions. One portion of collected cells was pelleted
and subjected to protein extraction using a HSB. The remaining pellet was subjected to 1! LB to extract insoluble receptor
aggregates. The other portion of the suspended cells was pelleted and the pellet was suspended with LB to extract both soluble and
insoluble proteins for TCL. 10 mg total protein was subjected to 10–18% SDS-PAGE. Proteins with (G) or without GFP were probed
with a receptor specific antibody. All experiments were replicated at least two independent times. (B) ChIP of transiently transfected
HeLa cells. Cells co-transfected with expression vector expressing an ERa cDNA and the reporter vector bearing the TATA box
promoter with single ERE for 24 h were treated without (NL) or with 10K9 M E2, 10
K7 4HT, or ICI for 1 h. Cells were then subjected to
ChIP using Flag-M2 antibody-conjugated agarose beads. A 366 bp PCR fragment indicates the ER–ERE interactions. Experiments
were replicated at least three independent times. (C) The in situ ERE binding competition assay. HeLa cells were co-transfected with
125 ng the TATA box promoter with one ERE that drives the expression of the firefly luciferase cDNA as the reporter enzyme and
300 ng expression plasmid bearing the designer transcription factor, PPVV, without (0 ng ER) or with 75, 150, or 300 ng expression
vector bearing an ER cDNAwith or without GFP. Cells were then grown in the medium supplemented without (NL) or with 10K9 M E2,
10K7 M 4HT, or ICI for 24 h. Normalized luciferase activity is presented as percent change compared with the control (PPVV, 0 ng
ER) without ligand, which was set to 100. Graph represents the mean of three independent experiments performed in duplicate;
S.E.M., which was!15% of the mean, is not shown for simplicity. (D) Transfected HeLa cells with an expression vector bearing none
(V) or an ERb cDNA were treated without (NL) or with 10K9 M E2, 10
K7 M 4HT, or ICI for 1 h. Cells were collected, pelleted, and
subjected to protein extraction using HSB. 10 mg total protein was subjected to 10–18% SDS-PAGE. Proteins were probed with a
receptor-specific antibody. The image is from an experiment that was repeated at least three independent times. (E) ChIP assays for
in situ interactions of ERb and ERbEBD with ERE in HeLa cells were carried out using the M2-Flag antibody-conjugated agarose
beads as described for ERa proteins. A representative image from an experiment repeated three independent times is shown.
(F) Transient transfections of HeLa cells for the assessment of the binding of ERb proteins with (G) or without ERE using the in situ
ERE binding competition assay are accomplished as described for ERa. The mean of three independent experiments performed in
duplicate without the S.E.M., which was !15% of the mean, is shown.
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Mobility and ERE interactions of ERs . M MUYAN and others 259ERE binding with a designer activator, PPVV, that
constitutively and potently induces transcription from
the TATA box promoter construct bearing single ERE
(ERE-TATA) at which ERs have minimal effect on
transcription (Huang et al. 2005b). Thereby,
interference of activator-mediated transcription by
unliganded or liganded ERs is taken as an indication
of ER–ERE interaction.
The reporter ERE-TATA plasmid was co-transfected
with an expression vector encoding the PPVV cDNA
into HeLa cells in the absence (0) or presence of
varying amounts (75, 150, and 300 ng/well) of an
expression vector bearing an ER cDNA (Fig. 5C).
Cells were then treated with or without 10K9 M E2,
10K7 M 4HT, or ICI for 24 h. As PPVV does not bind to
a ligand and consequently ligands do not affect the
transregulatory potential of PPVV (Huang et al.
2005b), the normalized luciferase activity mediated
by PPVV alone in the absence of a ligand was set to
100%. Alterations in the reporter enzyme activity as a
result of a co-transfected ER in the absence or presence
of a ligand are depicted as percentage change
compared with the activity induced by PPVV alone
(0 ng ER). Similar to results obtained with ChIP assay,
E2 or 4HT increased the ability of ERa or GFP-ERa
to interact with ERE reflected in a further repression
of the PPVV-induced luciferase activity by the unli-
ganded ERa with or without GFP. The treatment of
cells with ICI, on the other hand, had no effect on
enzyme levels induced by PPVV. This suggests that
ICI prevents the binding of ERa or GFP-ERa to ERE.
The effect of ERa in the absence or presence of
ligand on PPVV-mediated enzyme activity requires
ERE interactions as ERaEBD or GFP-ERaEBD did not
alter enzyme levels whether or not cells were exposed
to a ligand. Thus, the decrease in the nuclear mobility
of ERa mediated by E2 or 4HT is dependent upon the
ability of the receptor to interact with ERE, whereas
ICI sequesters the majority of the receptor to and
immobilizes at a nuclear sub-compartment, thereby
preventing ERa–ERE interactions.
In clear contrast to ERa, the short-term treatment
(1 h) of cells with ICI as E2 or 4HT did not affect
intracellular levels of ERb or ERbEBD with or without
GFP (Fig. 5D). The absence of an effect of ICI, as E2 or
4HT, on levels and mobilities of ERb proteins also
predicts that ICI does not alter ERb–ERE interactions
in situ. Indeed, ChIP (Fig. 5E) or the in situ ERE
binding competition assay (Fig. 5F) revealed that E2 or
ICI did not affect the binding of ERb or GFP-ERb to
ERE, whereas 4HT increased ERb–ERE interactions.
As expected, the ERbEBD with or without GFP did not
bind to ERE. These findings imply that the ligand-
mediated nuclear mobility of ERb is independent of
nature of ligands and the ability of ERb to bind to ERE.www.endocrinology-journals.orgEffects of ligands on transregulatory function and
nuclear mobility of GFP-ERs in MDA-MB-231 cells
To examine whether or not the effects of ligands on the
nuclear mobilities of ERs are cell type specific, we also
used ER-negative MDA-MB-231 cells derived from a
breast adenocarcinoma. Exogenously introduced ERa
or ERb in MDA-MB-231 cells modulates genomic and
cellular responses in the presence of E2 (Garcia et al.
1992, Zajchowski et al. 1993, Lazennec et al. 2001, Li
et al. 2008, Nott et al. 2009, Huang et al. 2011). In this
cell line, 4HT acts as an ERa subtype-specific agonist by
mimicking the effects of E2 on cellular responses when
mediated by the ERE-dependent signaling pathway,
whereas ICI is an antagonist for both ER subtypes
(Bentrem et al. 2001, Tonetti et al. 2003). The EREBD do
not interact with the ERE sequence of the estrogen-
responsive TFF1 gene with or without ligands, while
ligands differentially alter the parent ER–ERE inter-
actions (Supplementary Figure 5A, see section on
supplementary data given at the end of this article).
Moreover, providing evidence for a functional ERE-
independent signaling pathway, we recently showed that
the DNA binding-defective ERs participate in the fine-
tuning of phenotypic features of MDA-MB-231 cells by
regulating the expression of a subset of estrogen-responsive
genes (Li et al. 2008, Nott et al. 2009).
Transient transfections of MDA-MB-231 cells with
heterologous reporter vectors emulating ERE-depen-
dent and ERE-independent signaling pathways revealed
that the GFP fusion-ERs mimic the abilities of the
parent receptors to regulate transcription in response
to ligands (Supplementary Figures 5 and 6, see section
on supplementary data given at the end of this article).
The nuclear motilities of GFP-ERa with or without
ligands in MDA-MB-231 cells (Fig. 6) showed patterns
indistinguishable from those observed in HeLa cells.
However, the rate and the time of the total recovery of
ERa variants in response to E2 or 4HT were about
twofold slower than those of the receptor synthesized
in HeLa cells. The 1⁄2mRR of the unliganded GFP-ERa
or GFP-ERaEBD was !0.2 s with a total recovery within
5 s after photo-bleaching. The treatment of cells
with 10K9 M E2 or 10
K7 M 4HT in cells synthesizing
GFP-ERa increased the 1⁄2mRR of the bleached region
to about 11 and 9 s respectively with a full fluorescence
recovery occurring within 60 s of post-bleaching. ICI at
10K7 M effectively halted the fluorescence recovery of
GFP-ERa. As observed in HeLa cells, ICI also prevented
the recovery of the bleached region in the majority
of cells (more than 80%) synthesizing GFP-ERaEBD,
while the rate of fluorescence recovery vastly varied in
individual cells in the remaining population (data not
shown). These findings support our conclusion that the
DBD contributes to ICI-mediated immobilization of
ERa. On the other hand, the unliganded GFP-ERaEBDJournal of Molecular Endocrinology (2012) 49, 249–266
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Figure 6 The effects of ligands on the nuclear mobility of GFP fusion ER proteins in MDA-MB-231 cells. Transiently
transfected cells for 24 h were incubated in the absence (NL) or presence of 10K9 M E2, 10
K7 M 4HT, or ICI for 1 h and
subjected to FRAP analysis as described in the legend of Fig. 2. Graph represents the normalized mean fluorescence
recovery of GFP-ER with or without a ligand in three independent experiments with a minimum of five individual cells per
experiment. The S.E.M., which was !15% of the mean, is not shown.
M MUYAN and others . Mobility and ERE interactions of ERs260showed a very rapid recovery with a 1⁄2mRR of !0.2 s
with a full recovery occurring within 1 s. This was similar
to the rate of recovery of GFP-ERaEBD in cells exposed
to E2 or 4HT with the fluorescence equilibration
occurring within 10 s of post-bleaching. Thus, the
E2- or 4HT-mediated decrease in the nuclear mobility
of ERa is dependent upon the ability of the receptor
to interact with ERE and is independent of cell type.
The fluorescence recovery of GFP-ERb in the absence
or presence of a ligand was kinetically similar to that
of GFP-ERbEBD in MDA-MB-231 cells and mirrored
those observed in HeLa cells wherein the overall rate
of recovery was faster for both receptor species. In the
absence of ligand, the bleached region synthesizing
ERb or ERbEBD recovered within 40 s of post-bleaching
with a 1⁄2mRR of about 1 s. Treatment of cells with E2,
4HT, or ICI slowed the rate of fluorescence recovery
to about 25 s with a full recovery within 120 s post-
bleaching. Thus, the ability of ERb to bind to ERE is
not reflected in the nuclear mobility of the receptor,
which is also independent of the nature of ligand and
cell context.Structural domains responsible for ER subtype-
specific nuclear mobility
The amino- and carboxyl-termini of ERs functionally
differ (Cowley & Parker 1999, Hall & McDonnell 1999,
Yi et al. 2002a, Huang et al. 2005b). To examine the roles
of structural termini on the nuclear mobility of ERs,Journal of Molecular Endocrinology (2012) 49, 249–266we used GFP fusion ER chimera proteins. In ERaNbC
and ERbNaC, the entire amino-termini of the receptors
are genetically interchanged (Yi et al. 2002a). We found
in transiently transfected HeLa cells that the fluor-
escence recoveries of ERaNbC with or without a
functional ERE binding (data not shown) were
kinetically similar to those observed with ERbs in the
absence or presence of ligands (Fig. 7). Conversely,
ERbNaC or the ERE binding-defective ERbNaC
mimicked the nuclear mobilities of ERa proteins with
or without a ligand (data not shown). These results
indicate that the carboxyl-termini are the structural
basis for the difference in the nuclear mobility of ER
subtypes in the absence or presence of a ligand.
Distinct conformational features of ER carboxyl-
termini induced by a ligand determine the formation
of a functional co-regulator interacting surface respon-
sible for AF2 of the receptors. We also addressed
whether the changing of the critical residues that
prevent AF2 affects the subtype-specific nuclear mobi-
lity of ERs in response to ligands. To examine this issue,
we used the GFP-fusion ERs with abrogated AF2
(ERAF2). In transiently transfected HeLa cells, the
nuclear mobility of the unliganded, E2- or 4HT-bound
GFP-ERaAF2 showed kinetics of mobility (Fig. 8A)
similar to that of ERa (Fig. 2). GFP-ERaAF2 was also
mobile when ICI was present. This suggests that the
absence of AF2 renders ERa mobile when ICI is
present. ICI, as E2 or 4HT, also had minimal effects
on the FRAP of the ERE binding-defective receptor withwww.endocrinology-journals.org
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Figure 7 The nuclear mobility of the chimeric ERaNbC in HeLa
cells. Transiently transfected cells for 24 h were incubated in the
absence (NL) or presence of 10K9 M E2, 10
K7 M 4HT, or ICI for
1 h. Cells were subjected to FRAP analysis as described in the
legend of Fig. 2. Graph represents the normalized mean
fluorescence recovery of GFP-ERaNbC from three independent
experiments with a minimum of five individual cells per
experiment. S.E.M., which was !15% of the mean, is not shown
for simplicity.
Mobility and ERE interactions of ERs . M MUYAN and others 261abrogated AF2, GFP-ERaEBDCAF2 (Fig. 8B). ERaAF2 or
ERaEBDCAF2 without or with GFP was HSB extractable
(Fig. 8C). Moreover, ICI-ERaAF2 gained the ability to
interact with ERE in situ (Fig. 8D) in stark contrast to
ICI-ERa, which was immobile due to the sequestration
to a nuclear sub-compartment resistant to HSB
extraction. However, ERaAF2 with or without GFP was
transcriptionally inactive when cells were treated with
ICI, E2, or 4HT (Fig. 8E). Thus, it appears that the
ligand-mediated nuclear mobility and the ability to
interact with and to induce transcription from target
sites of ERa are discernable. A much faster kinetics
of mobility of ERaEBD compared with that of ERa in
response to E2 or 4HT also indicate that the mobility
of ERa at the ERE-independent signaling pathway
contributes fractionally to the overall nuclear mobility
of the receptor.
The prevention of AF2 did not alter the pattern or
the kinetic of mobility of the GFP-ERbAF2 mutant
compared with that of the GFP-ERb in the absence or
presence of ligands (Fig. 9A). The pattern of fluor-
escence recovery of GFP-ERbEBDCAF2 was also similar to
that of GFP-ERbAF2 (Fig. 9B). Interestingly, however,
the nuclear movement of GFP-ERbEBDCAF2 occurred at
slower kinetics than GFP-ERbEBD or GFP-ERbAF2 in thewww.endocrinology-journals.orgabsence or presence of ligands. The fluorescence level
of the bleached region in cells synthesizing ERbEBDCAF2
in the absence of ligand reached pre-bleach levels with
a 1⁄2mRR of about 6 s, whereas the fluorescence recovery
in cells synthesizing GFP-ERbEBD or GFP-ERbAF2 was
about 1 s. The treatment of cells with E2, 4HT, or ICI
decreased the mobility of ERbEBDCAF2 similarly,
reflected in a 1⁄2mRR of about 20 s in comparison with
liganded GFP-ERbEBD that showed recovery rates of
about 15 s. This suggests that integrated effects of the
DBD and the LBD of ERb are important for the mobility
characteristics of ERb.
Ligands did not affect the intracellular levels of the
receptor species (Fig. 9C). The treatment of cells with
or without a ligand did not alter the ability of ERbAF2 or
GFP-ERbAF2 to interact with ERE in situ (Fig. 9D),
despite the fact that the receptors were transcriptionally
silent at simulated ERE-dependent and ERE-indepen-
dent signaling pathways (Fig. 9E). Showing similar
intracellular levels in the absence or presence of a
ligand (Fig. 9C), ERbEBDCAF2 with or without GFP did
not bind to ERE (Fig. 9D) nor did it modulate the
reporter enzyme levels whether or not cells were treated
with a ligand (Fig. 9E).
Thus, the nuclear mobility of ERb is independent
from the nature of ligand and from the ability of the
receptor to interact with target sites. These results imply
that ERb mediates gene transcription through the
ERE-dependent and ERE-independent signaling
pathways with similar kinetics.Discussion
ERs are highly mobile proteins partitioned dynamically
between the nucleoplasm and target sites on the
chromatin that constitute the ERE-dependent and
ERE-independent signaling pathways. We here assessed
the relative contribution of ER mobility at the ERE-
independent signaling pathway to the overall mobility
of receptors to gain insights into mechanisms of action.
Our observations revealed several distinct features of
ERb mobility compared with ERa. These are as follows:
i) ERb mobility with or without ligands is slower than
ERa mobility. ii) The interaction of ERb with ERE is
augmented with 4HT but not with E2 or ICI, whereas E2
and 4HT enhance and ICI prevents ERa–ERE
interactions. iii) ICI does not sequester ERb with or
without ERE binding and/or AF2 functions to a nuclear
sub-compartment, whereas the sequestration of ERa is
dependent on AF2. iv) The ability of ERb to interact
with and to induce transcription from target sites
is largely uncoupled from the receptor mobility.
v) Cooperation between DBD and LBD contributes to
ERb motility. Based on these observations, we conclude
that while ICI immobilizes ERa to a sub-nuclearJournal of Molecular Endocrinology (2012) 49, 249–266
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Figure 8 The nuclear mobility of the GFP-ERaAF2 with GFP-ERaEBDCAF2 in HeLa cells. Transiently transfected cells for 24 h were
incubated in the absence (NL) or presence of 10K9 M E2, 10
K7 M 4HT, or ICI for 1 h. Cells synthesizing GFP-ERaAF2 (A) or
GFP-ERaEBDCAF2 (B) were subjected to FRAP analysis as described in the legend of Fig. 2. Graphs represent the normalized mean
fluorescence recovery of ERa proteins from three independent experiments with a minimum of five individual cells per experiment.
The S.E.M., which was!15% of the mean, is not shown for simplicity. (C) Intracellular levels of ERaAF2 and ERaEBDCAF2 with (G) or
without in transiently transfected in HeLa cells for 24 h. Cells were then treated in the absence or presence of 10K9 M E2,
10K7 M 4HT, or ICI for 1 h. Cells were collected, pelleted, and subjected to protein extraction using HSB. 10 mg total protein was
subjected to 10–18% SDS-PAGE. Proteins were probed with a receptor-specific antibody. Experiments were repeated two
independent times. (D) Assessing the effects of ligands on in situ ERE binding abilities of ERaAF2 and ERaEBDCAF2 with (G) or
without GFP. Transiently transfected HeLa cells were treated in the absence or presence of a ligand for 24 h. Graphs depict the
mean of three independent experiments performed in duplicate. The S.E.M., which was !15% of the mean, is not shown for
simplicity. (E) The effects of ligands on transcription by ERaAF2 and ERaEBDCAF2 with (G) or without GFP. Cells were transfected with
the 2XERE or the MMP1-Luc promoter reporter vector emulating the ERE-dependent or ERE-independent signaling pathway. Cells
were also co-transfected with a vector expressing ERaAF2 and ERaEBDCAF2 with (G) or without GFP. Cells were then treated in the
absence or presence of a ligand for 24 h for the luciferase activity for 24 h. Graphs represent the mean of three independent
experiments performed in duplicate. The S.E.M., which was !15% of the mean, is not shown.
M MUYAN and others . Mobility and ERE interactions of ERs262compartment, E2 or 4HT decreases ERa mobility by
increasing ERa–ERE interactions. We therefore suggest
that ERa in response to E2 and 4HT mediates
transcriptions from the ERE-independent pathway
with remarkably fast kinetics that contributes fraction-
ally to the overall motility of the receptor. On the other
hand, the ligand-mediated mobility of ERb is indepen-
dent of the nature of ligands or the mode of interaction
with target sites. It therefore appears that although ERs
interact with target sites with fast kinetics, they use
distinct mechanisms to regulate transcriptions at
signaling pathways.
We show here, as previous studies (Sharp et al. 2006,
Zwart et al. 2010), that 4HT, as E2, decreases theJournal of Molecular Endocrinology (2012) 49, 249–266mobility of ERa by enhancing ERa–ERE interactions
(Shang et al. 2000, Huang et al. 2005b). However, the
underlying mechanism(s) remains unclear. The bind-
ing of tamoxifen to ERa alters conformation (Paige
et al. 1999) that affects co-activator recruitment (Yi et al.
2002b). Tamoxifen-ERa can also recruit co-repressors
for transcription repression (Lavinsky et al. 1998,
Delage-Mourroux et al. 2000, Shang et al. 2000). While
4HT is an antagonist for ERa in HeLa cells, it acts
as an agonist in MDA-MB-231 cells (Bentrem et al. 2001,
Tonetti et al. 2003). 4HT was also augmented ERa–ERE
interactions. 4HT-ERa showed mobility similar to
E2–ERa. On the other hand, ERaEBD with or without
AF2 was kinetically much faster when bound to 4HT orwww.endocrinology-journals.org
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that E2- and 4HT-mediated decreases in ERa mobility
are due to the residency time of the receptor on ERE
independent of transcription. By contrast, ICI immobi-
lized ERa. ICI binding prevents ER-co-regulator
interactions (Yi et al. 2002b) but drives ERa to interact
with cytokeratins through LBD (Long & Nephew 2006).
Leading to the association of ICI-ERa with nuclear
matrix (Long & Nephew 2006, Lupien et al. 2007), this
could result in the immobilization and complete
prevention of ERE interactions, as shown here and
previously (Reid et al. 2003). However, it was also shown
that a fraction of ICI-ERa remains associated with
the prolactin promoter array, which is composed of
52 prolactin gene promoters containing multiple EREs
(Sharp et al. 2006). It is possible that while the majority
of ERa bound to ICI is immobilized to a sub-nuclear
region, a fraction of ERa bound to EREs of the
promoter array cooperatively and hence stably
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Figure 9 The mobilities of GFP-ERbAF2 and GFP-ERbEBDCAF2 in H
(A)GFP-ERbAF2 or (B)GFP-ERbEBDCAF2 for FRAPwere carried out as
proteins were analyzed with high salt extracts of transfected HeLa cell
Fig. 8C. (D) The effects of ligands on in situERE binding abilities of ER
described in the legend of Fig. 8D. The S.E.M., which was !15% of th
transcription by ERbAF2 andERbEBDCAF2 with (G) or without GFPwere
mean of three independent experiments performed in duplicate. The
www.endocrinology-journals.orgfrom the array in contrast to the single ERE of the
reporter system and the endogenous gene we used
here. Another puzzling observation is that while ICI
immobilized ERa, ICI-ERa still modulated the reporter
gene transcription from ERE-independent pathways.
Immobilization of ERa by ICI could prevent the
interaction of ER with co-regulators/transfactors
thereby countering the ERa-mediated repressed or
activated state of transcriptions.
The changing (Fig. 8) or deletion (Sharp et al. 2006)
of critical residues to block AF2 rendered ICI-ERa
mobile in cells. This was reflected in the increased
extractability of ERa with HSB or detergent likely
due to the inability of the receptor to interact with
cytokeratins (Long & Nephew 2006). Nevertheless,
ICI-ERaAF2 was transcriptionally silent despite the
fact that the receptor interacted with ERE. Moreover,
the increased mobility of ERaEBDCAF2 regardless
of the nature of ligand strengthens the conclusion































































































eLa cells. The transfection and processing of cells synthesizing
described in the legend of Fig. 2. (C) Intracellular level of receptor
s, which were treated and processed as described in the legend of
bAF2 and ERbEBDCAF2 with (G) or without GFPwere assessed as
e mean, is not shown for simplicity. (E) The effects of ligands on
assessed as described in the legend of Fig. 8E. Graphs show the
S.E.M., which was !15% of the mean, is not shown.
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transcription status. This lends further credence to
the hit-and-run model of transcription for ERa
regardless of signaling pathway.
In contrast to ERa, ERb and ERbEBD showed
indistinguishable mobility rates independent of the
nature of ligands and the ability of the receptor to
interact with target sites and cellular context. Consequ-
ently, it appears that ERb mediates gene transcriptions
through the ERE-dependent and ERE-independent
signaling pathways with similar kinetics. ERs share
structural features reflected in similar functional
properties. ERs nevertheless exhibit distinct trans-
regulatory potentials at signaling pathways. The
amino-termini are critical regions that contribute to
subtype-specific transcriptional responses. In contrast
to ERa, the ERb amino-terminus impairs ER–ERE
interactions (Huang et al. 2005b), lacks an AF (Cowley
& Parker 1999, Yi et al. 2002a), and does not interact
with the carboxyl-terminus (Yi et al. 2002a). However,
the amino-termini do not appear to contribute to
distinct receptor mobility. We observed that the
mobilities of the ERaNbC chimeras were kinetically
similar to those observed with ERb variants. ERbNaC, on
the other hand, mimicked ERa mobility in response to
ligands. These imply that the carboxyl-termini are
critical regions in defining mobility differences of
ERs. Studies also showed that the carboxyl-termini
contribute to transcriptional potencies of ERs (Yi et al.
2002a) by differentially interacting with co-regulators
(Seol et al. 1998, Kressler et al. 2002). Moreover, some
co-regulator interactions with ERs are specific to the
nature of the ligand. The unliganded ERa interacts
with co-repressors SMRT/NCoR (Lavinsky et al. 1998,
Webb et al. 2003). The binding of E2 releases
co-repressors from ERa (Lavinsky et al. 1998, Webb
et al. 2003). The unliganded ERb also interacts with
SMRT/NCoR through the carboxyl-terminus (Webb
et al. 2003). However, the binding of E2 does not
promote co-repressor dissociations (Webb et al. 2003).
By contrast, the binding of 4HT or ICI releases SMRT/
NCoR from ERb but not from ERa (Lavinsky et al.
1998, Webb et al. 2003). As ERb requires E2 to regulate
transcription from the ERE-dependent signaling
pathway, E2 binding could act as a switch to convert
ERb to an active state by concurrently recruiting
co-activators likely through a distinct surface.
We also found that 4HT enhanced the ERb–ERE
interaction in contrast to E2 or ICI. Although is unclear,
distinct trans-conformational changes in ERb-DBD
mediated by the binding of 4HT to LBD could underlie
the effect of 4HT on ERb–ERE interactions. We
observed that 4HT- or ICI-bound ERb, as ERbAF2,
showed mobility similar to E2–ERb despite the fact
that the receptor was transcriptionally inactive at
the ERE-dependent pathway. Furthermore, ERbEBDJournal of Molecular Endocrinology (2012) 49, 249–266mobility was indistinguishable from that of ERb
independently of ligands. However, ERbEBDCAF2
showed slower mobility than ERbEBD. This suggests
that the cooperation of AF2 with the ability of the
receptor to interact with target sites is a critical feature
for the nuclear mobility of ERb.
In summary, our results indicate that while ERs use a
hit-and-run mode of action, they differ mechanistically
to modulate transcriptions. The use of integrated
promoter arrays mimicking various signaling pathways
would yield further insights into mechanisms of ER
actions. This in turn could aid in the development of
better strategies to combat estrogen target tissue
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